These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 830926)

  • 41. The effect of cimetidine on maldigestion in cystic fibrosis.
    Cox KL; Isenberg JN; Osher AB; Dooley RR
    J Pediatr; 1979 Mar; 94(3):488-92. PubMed ID: 423042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fat malabsorption in cystic fibrosis patients.
    Murphy J; Laiho K; Wootton S
    Am J Clin Nutr; 1999 Nov; 70(5):943-6. PubMed ID: 10539762
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapy of mucoviscidosis].
    Stephan U
    Monatsschr Kinderheilkd (1902); 1968 Mar; 116(3):81-4. PubMed ID: 5688134
    [No Abstract]   [Full Text] [Related]  

  • 44. Iatrogenic hyperuricemia in children with cystic fibrosis.
    Davidson GP; Hassel FM; Crozier D; Corey M; Forstner GG
    J Pediatr; 1978 Dec; 93(6):976-8. PubMed ID: 722445
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of malabsorption].
    Weijers HA
    Maandschr Kindergeneeskd; 1969 Oct; 37(4):110-2. PubMed ID: 5345410
    [No Abstract]   [Full Text] [Related]  

  • 46. Options for addressing exocrine pancreatic insufficiency in patients receiving enteral nutrition supplementation.
    Freedman SD
    Am J Manag Care; 2017 Jul; 23(12 Suppl):S220-S228. PubMed ID: 28727476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of cystic fibrosis].
    Kjellmer I; Kollberg H; Kornfält R; Lindberg T; Strandvik B
    Lakartidningen; 1976 Mar; 73(10):855-8. PubMed ID: 1256132
    [No Abstract]   [Full Text] [Related]  

  • 48. Desensitization to pancreatic enzyme intolerance in a child with cystic fibrosis.
    Chamarthy LM; Reinstein LJ; Schnapf B; Good RA; Bahna SL
    Pediatrics; 1998 Jul; 102(1):e13. PubMed ID: 9651465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative trial of pancrex V forte and nutrizym in treatment of malabsorption in cystic fibrosis.
    Goodchild MC; Sagaró E; Brown GA; Cruchley PM; Jukes HR; Anderson CM
    Br Med J; 1974 Sep; 3(5933):712-4. PubMed ID: 4606368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts.
    Benabdeslam H; Garcia I; Bellon G; Gilly R; Revol A
    Am J Clin Nutr; 1998 May; 67(5):912-8. PubMed ID: 9583849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potato crisps without pancreatic extracts supplements: a potential cause of the distal intestinal obstruction in cystic fibrosis.
    Kopriva F; Michálková K; Zápalka M; Malý J
    Eur J Pediatr; 2007 Sep; 166(9):969-70. PubMed ID: 17124589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nutritional considerations of pancreatic enzyme therapy in cystic fibrosis. An international symposium. Oslo, Norway, June 18, 1987.
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S1-57. PubMed ID: 3404357
    [No Abstract]   [Full Text] [Related]  

  • 54. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal manifestations of cystic fibrosis.
    Riedel BD
    Pediatr Ann; 1997 Apr; 26(4):235-41. PubMed ID: 9114442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The nutritional management of children with cystic fibrosis.
    Laing SC
    Hum Nutr Appl Nutr; 1986 Feb; 40(1):24-31. PubMed ID: 3082805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy.
    Braden B; Picard H; Caspary WF; Posselt HG; Lembcke B
    Z Gastroenterol; 1997 Feb; 35(2):123-9. PubMed ID: 9066102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficiency of two pancreatic extracts in patients with cystic fibrosis.
    Baran D; Loeb H; Mozin MJ
    Acta Paediatr Belg; 1976; 29(2):117-22. PubMed ID: 998217
    [No Abstract]   [Full Text] [Related]  

  • 60. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.